Kidney Stones Clinical Trial
Official title:
The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients
Verified date | October 2016 |
Source | William Beaumont Hospitals |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
To determine if emergency department patients with acute ureteral colic pain due to a ureteral stone who are treated with tamsulosin, versus placebo, will experience a shorter time to passage of their stone or resolution of their pain. A secondary study objective will be to determine if there is a relationship between response to tamsulosin and stone size or position in the ureter.
Status | Completed |
Enrollment | 127 |
Est. completion date | September 2011 |
Est. primary completion date | September 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Emergency Department patients with acutely symptomatic renal colic pain - Confirmation of a symptomatic stone will be made by imaging (helical CT scan or intravenous pyelogram). Exclusion Criteria: - Stones not documented on imaging - Stones >10mm - Pregnancy - Age <18 years - Evidence of infection with an obstructing stone - Obstructing stone in a solitary kidney - Currently taking tamsulosin, vardenafil, nifedipine, or steroids - Contraindications or allergy to tamsulosin - Ureteral surgery - Patients that are unable to understand consent - Patients that are unable to comply with follow-up |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | William Beaumont Hospital | Royal Oak | Michigan |
Lead Sponsor | Collaborator |
---|---|
Robert Swor | William Beaumont Hospitals |
United States,
Berger DA, Ross MA, Hollander JB, Ziadeh J, Chen C, Jackson RE, Swor RA. Tamsulosin does not increase 1-week passage rate of ureteral stones in ED patients. Am J Emerg Med. 2015 Dec;33(12):1721-4. doi: 10.1016/j.ajem.2015.08.006. Epub 2015 Aug 7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stone Passage | Participants were asked during the follow-up phone call to indicate if their stone had passed within seven days. Phone calls were conducted at days 1, 2, 3, 7, 10 and 30 days after the emergency department discharge. Data is reported based on the information obtained up to the 7th day. | 1-7 days | No |
Secondary | Amount (Mean Number of Tablets Taken) of Pain Medication Taken by Subjects up to Seven (7) Days Post Emergency Department Discharge | 1-7 days | No | |
Secondary | High Pain Score by Treatment Group | Severity of Patient Pain at 7 days Post Emergency Department Visit. Patients were asked to describe their pain severity at each followup phone call, using a numerical scale, ranging from 0 (no pain) to 10 (worst possible pain). We report this measure at 7 days. | 7 Days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02579161 -
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
|
Phase 3 | |
Completed |
NCT01187745 -
Study to Look for Artifact on Computed Tomography (CT) Representing Kidney Stones
|
N/A | |
Withdrawn |
NCT00875823 -
International Registry for Primary Hyperoxaluria
|
N/A | |
Completed |
NCT05519150 -
Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
|
||
Recruiting |
NCT02522689 -
Comparison of Ultra-mini PCNL and Micro PCNL
|
N/A | |
Recruiting |
NCT01514032 -
Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones
|
N/A | |
Completed |
NCT00873054 -
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
|
N/A | |
Completed |
NCT00765128 -
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
|
Phase 4 | |
Withdrawn |
NCT00583258 -
A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
|
N/A | |
Active, not recruiting |
NCT03630926 -
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Completed |
NCT03095885 -
A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
|
N/A | |
Completed |
NCT01330940 -
Effect of Diet Orange Soda on Urinary Lithogenicity
|
N/A | |
Completed |
NCT01088555 -
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
|
N/A | |
Recruiting |
NCT00489723 -
Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?
|
N/A | |
Recruiting |
NCT05417568 -
Oxalate-Driven Host Responses in Kidney Stone Disease
|
N/A | |
Recruiting |
NCT02375295 -
Struvite Stones Antibiotic Study
|
Phase 4 | |
Enrolling by invitation |
NCT02408211 -
Preoperative Antibiotic PNL Study
|
Phase 4 | |
Withdrawn |
NCT01560091 -
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
|
Phase 3 |